Oral evidence transcript
| Published on: | Monday 11 March 2019 |
|---|---|
| Date: | Thursday 7 March 2019 |
| Meeting on: | Thursday 7 March 2019 |
| Part of event segment: | Untitled |
| Document ID: | 158247 |
| Citations: |
|
Committees
Work packages
-
Availability of Orkambi on the NHS inquiry
Friday 30 November 2018 - Friday 30 November 2018
Witnesses
-
A patient representative nominated by the Cystic Fibrosis Trust, a clinician representative nominated by the Cystic Fibrosis TrustProfessor Stephen Powis, National Medical Director, John Stewart, National Director, Specialised Commissioning, NHS England, Sir Andrew Dillon, Chief Executive, Meindert Boysen, Director of the Centre for Health Technology Evaluation, NICEDr Jeff Leiden, Chairman, President and Chief Executive Officer, Stuart A. Arbuckle, Executive Vice President and Chief Commercial Officer, Vertex Pharmaceuticals